CT-P6

DRUG2 trials

Sponsors

Celltrion

Conditions

Metastatic Breast Cancer

Phase 1

Evaluate Safety, Efficacy and Pharmacokinetics

CompletedNCT01084863

CelltrionMetastatic Breast Cancer

Start: 2010-02-28End: 2023-12-31Updated: 2025-01-24

Phase 3

Demonstrate Efficacy and Safety of Metastatic Breast Cancer

CompletedNCT01084876

CelltrionMetastatic Breast Cancer

Start: 2010-06-30End: 2015-03-31Updated: 2025-02-11